Concentrix [CNXC] vs Epam Systems [EPAM] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Concentrix wins in 8 metrics, Epam Systems wins in 10 metrics, with 0 ties. Epam Systems appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricConcentrixEpam SystemsBetter
P/E Ratio (TTM)10.2221.99Concentrix
Price-to-Book Ratio0.692.34Concentrix
Debt-to-Equity Ratio111.134.44Epam Systems
PEG Ratio0.02-2.51Epam Systems
EV/EBITDA5.2610.79Concentrix
Profit Margin (TTM)3.25%7.91%Epam Systems
Operating Margin (TTM)5.92%9.63%Epam Systems
EBITDA Margin (TTM)5.92%9.63%Epam Systems
Return on Equity7.43%11.35%Epam Systems
Return on Assets (TTM)3.85%8.49%Epam Systems
Free Cash Flow (TTM)$428.73M$527.02MEpam Systems
Dividend Yield3.51%N/AN/A
1-Year Return-0.83%-21.80%Concentrix
Price-to-Sales Ratio (TTM)0.311.69Concentrix
Enterprise Value$7.48B$7.71BEpam Systems
EV/Revenue Ratio0.771.52Concentrix
Gross Profit Margin (TTM)N/A28.77%N/A
Revenue per Share (TTM)$153$89Concentrix
Earnings per Share (Diluted)$4.72$7.01Epam Systems
Beta (Stock Volatility)0.551.66Concentrix
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Concentrix vs Epam Systems Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Concentrix-1.49%-0.61%-9.52%-16.13%0.74%9.19%
Epam Systems-1.04%-1.29%-7.26%-15.26%5.22%-33.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Concentrix-0.83%-59.61%-40.58%-40.58%-40.58%-40.58%
Epam Systems-21.80%-53.35%-56.50%92.54%992.48%992.48%

News Based Sentiment: Concentrix vs Epam Systems

Concentrix

News based Sentiment: MIXED

Concentrix reported mixed Q3 results with a revenue beat but EPS and EBITDA misses, leading to lowered guidance. However, the company continues to invest in AI and return capital to shareholders, creating a complex investment narrative with both positive and negative elements.

View Concentrix News Sentiment Analysis

Epam Systems

News based Sentiment: POSITIVE

EPAM’s Q2 2025 earnings significantly exceeded expectations, leading to raised guidance and positive analyst upgrades. This, combined with strategic initiatives in AI and immersive experiences, creates a positive investment narrative for the month.

View Epam Systems News Sentiment Analysis

Performance & Financial Health Analysis: Concentrix vs Epam Systems

MetricCNXCEPAM
Market Information
Market Cap i$3.10B$8.64B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,434,880756,400
90 Day Avg. Volume i944,133845,563
Last Close$47.54$152.51
52 Week Range$36.28 - $66.00$138.15 - $269.00
% from 52W High-27.97%-43.30%
All-Time High$208.48 (Feb 07, 2022)$725.40 (Nov 01, 2021)
% from All-Time High-77.20%-78.98%
Growth Metrics
Quarterly Revenue Growth0.04%0.18%
Quarterly Earnings Growth4.30%-0.11%
Financial Health
Profit Margin (TTM) i0.03%0.08%
Operating Margin (TTM) i0.06%0.10%
Return on Equity (TTM) i0.07%0.11%
Debt to Equity (MRQ) i111.134.44
Cash & Liquidity
Book Value per Share (MRQ)$69.83$65.85
Cash per Share (MRQ)$5.63$18.70
Operating Cash Flow (TTM) i$648.78M$449.58M
Levered Free Cash Flow (TTM) i$3.74B$540.61M
Dividends
Last 12-Month Dividend Yield i3.51%N/A
Last 12-Month Dividend i$1.68N/A

Valuation & Enterprise Metrics Analysis: Concentrix vs Epam Systems

MetricCNXCEPAM
Price Ratios
P/E Ratio (TTM) i10.2221.99
Forward P/E i3.9213.77
PEG Ratio i0.02-2.51
Price to Sales (TTM) i0.311.69
Price to Book (MRQ) i0.692.34
Market Capitalization
Market Capitalization i$3.10B$8.64B
Enterprise Value i$7.48B$7.71B
Enterprise Value Metrics
Enterprise to Revenue i0.771.52
Enterprise to EBITDA i5.2610.79
Risk & Other Metrics
Beta i0.551.66
Book Value per Share (MRQ) i$69.83$65.85

Financial Statements Comparison: Concentrix vs Epam Systems

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CNXCEPAM
Revenue/Sales i$2.37B$1.30B
Cost of Goods Sold i$1.52B$952.01M
Gross Profit i$855.90M$349.68M
Research & Development iN/AN/A
Operating Income (EBIT) i$168.87M$99.33M
EBITDA i$334.50M$151.42M
Pre-Tax Income i$100.79M$94.42M
Income Tax i$30.54M$20.94M
Net Income (Profit) i$70.26M$73.48M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CNXCEPAM
Cash & Equivalents i$308.00M$1.17B
Total Current Assets i$2.96B$2.42B
Total Current Liabilities i$1.79B$789.12M
Long-Term Debt i$4.90B$118.67M
Total Shareholders Equity i$4.03B$3.64B
Retained Earnings i$1.24B$2.47B
Property, Plant & Equipment i$0$327.67M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CNXCEPAM
Operating Cash Flow i$231.10M$82.27M
Capital Expenditures i$-55.79M$-9.33M
Free Cash Flow i$180.74M$14.83M
Debt Repayment i$-1.45B$-684,000
Common Stock Repurchase i$-46.82M$-160.00M

Short Interest & Institutional Ownership Analysis

MetricCNXCEPAM
Shares Short i7.66M1.87M
Short Ratio i12.272.26
Short % of Float i0.15%0.04%
Average Daily Volume (10 Day) i1,434,880756,400
Average Daily Volume (90 Day) i944,133845,563
Shares Outstanding i64.24M56.87M
Float Shares i35.03M53.79M
% Held by Insiders i0.16%0.04%
% Held by Institutions i0.98%0.97%

Dividend Analysis & Yield Comparison: Concentrix vs Epam Systems

MetricCNXCEPAM
Last 12-Month Dividend i$1.68N/A
Last 12-Month Dividend Yield i3.51%N/A
3-Year Avg Annual Dividend i$1.33N/A
3-Year Avg Dividend Yield i0.49%N/A
3-Year Total Dividends i$4.00N/A
Ex-Dividend DateOct 24, 2025N/A